Ep. 95 – Pregnancy, Rheumatoid Arthritis & Resilience

What happens when a researcher studying pregnancy becomes a patient navigating her own autoimmune diagnosis? In this powerful episode of The MotherToBaby Podcast, genetic counselor Chris Stallman, CGC, sits down with Dr. Christina Longo, Assistant Professor at the University of Montreal and perinatal epidemiologist, to discuss her lived experience managing rheumatoid arthritis during pregnancy and breastfeeding.

Dr. Longo shares how her first diagnosis during pregnancy reshaped her research focus—from child outcomes to the importance of maternal health, mental wellbeing, and self-advocacy. She opens up about the difficult decisions she faced around medication safety, breastfeeding, and treatment during pregnancy, and how patient-led communities and research studies helped her find strength and clarity.



Listeners will learn:

  • How autoimmune diseases can change during pregnancy and postpartum
  • Why controlled treatment plans matter before conception
  • The emotional and physical toll of navigating chronic illness while pregnant
  • The importance of participating in pregnancy studies to improve care for future parents

Whether you’re living with a chronic condition, supporting someone who is, or counseling patients through pregnancy, this episode sheds light on the urgent need for research, empathy, and balanced care for both parent and baby.

🔗 Learn more or join a pregnancy study.

    💡 Have questions about exposures during pregnancy or breastfeeding?
    You can contact MotherToBaby for free, confidential, evidence-based information:
    📞 Call: 866-626-6847
    📱 Text: 855-999-3525
    💻 Visit: https://mothertobaby.org/


    Ep. 95 – Pregnancy, Rheumatoid Arthritis & Resilience

    How do public health experts detect emerging risks to pregnancies before they become widespread crises? In this episode of The MotherToBaby Podcast, host Chris Stallman, genetic counselor, mom of four, and teratogen information specialist, sits down with Dr. Amanda Elmore, Assistant Professor of Maternal & Child Health at the University of South Florida, to explore the powerful role of birth defect surveillance.

    Dr. Elmore shares how her career in public health began during the Zika virus epidemic—reviewing medical records of exposed infants to help the CDC understand the real-world impact of in-utero exposure. She explains how surveillance systems track structural and functional birth anomalies, serve as early warning systems for new and emerging exposures, and shape everything from clinical care and referral services to national public health policy.



    The conversation also dives into:

    • How surveillance led to rapid public health responses during the Zika crisis
    • What neonatal abstinence syndrome (NAS) reveals about opioid exposure during pregnancy
    • The push for real-time data using electronic medical records and health information exchanges
    • How machine learning and natural language processing may transform how cases are identified
    • Why a life-course perspective matters for children born with birth defects
    • How surveillance data supports funding, prevention efforts, and long-term family services

    Dr. Elmore also shares her vision for the future: a more standardized, timely, and integrated national system that can better support prevention, research, and lifelong care for affected children and families.

    This episode offers a behind-the-scenes look at how data quietly powers some of the most important protections for moms and babies.

    💡 Have questions about exposures during pregnancy or breastfeeding?
    You can contact MotherToBaby for free, confidential, evidence-based information:
    📞 Call: 866-626-6847
    📱 Text: 855-999-3525
    💻 Visit: https://mothertobaby.org/


    Ep. 95 – Pregnancy, Rheumatoid Arthritis & Resilience

    In this special Folic Acid Awareness Week episode of The MotherToBaby Podcast, host and genetic counselor Chris Stallman sits down with Dr. Elisabeth Marnik, PhD—a biomedical scientist, mom, and science communicator better known as @ScienceWhizLiz on Instagram. Together, they unpack the science behind folic acid, its critical role in early pregnancy, and why it’s one of the most important (yet misunderstood) nutrients for people of childbearing age.

    From real talk on neural tube defect prevention to busting social media myths like “folic acid causes tongue ties” or “MTHFR mutations mean folic acid isn’t safe,” this episode is packed with science-backed insights and practical guidance for both healthcare providers and future parents alike.



    🧠 Key Topics Covered:

    • What folic acid is and why it matters for pregnancy
    • The difference between folic acid and folate
    • When folic acid is most critical (hint: before you know you’re pregnant!)
    • Myths and misinformation about folic acid—especially on social media
    • What the research really says about MTHFR gene mutations
    • How to support patients with dietary restrictions or supplement concerns
    • Why more folic acid is not always better

    👩‍⚕️ Guest Bio:
    Dr. Elisabeth Marnik is a biomedical scientist with a PhD from Tufts University and The Jackson Laboratory, where she studied immune system function, autoimmune disease, and vaccine response. She’s also a passionate science communicator who makes complex topics clear and relatable for thousands of followers as @ScienceWhizLiz on Instagram.

    🔗 Resources Mentioned:

    💬 Have a Question or Topic Idea?
    We’d love to hear from you! Email us at contactus@mothertobaby.org.

    📱 Subscribe & Listen On:
    Spotify | Apple Podcasts | Audible | iHeartRadio | Or wherever you get your podcasts

    💛 Support Our Work:
    Help us keep this podcast free and accessible. Join our monthly giving community, Encircle, to support parents and families with trusted pregnancy and breastfeeding information. Learn more at MotherToBaby.org/Donate


    Ep. 95 – Pregnancy, Rheumatoid Arthritis & Resilience

    In this session, Christina Chambers, PhD, MPH, a perinatal epidemiologist from UC San Diego and Principal Investigator of MotherToBaby Pregnancy Studies, reviews what is known and what still requires further study on the use of alcohol, cannabis and other substances by breastfeeding women, and how this translates to clinical practice. Participants should leave this session with a better understanding of the potential effects of substance use on infant growth and development, how knowledge gaps in this area are being addressed, and how to translate current knowledge into clinical situations in midwife practice.

    Participants will gain a clearer understanding of the potential short- and long-term impacts of maternal substance use on infants and learn how ongoing research is addressing current knowledge gaps. The session will also focus on translating this evidence into practical clinical guidance, including strategies for counseling breastfeeding women, supporting informed decision-making, and integrating risk assessment into midwifery care.

    This webinar is designed to enhance the knowledge and clinical skills of midwives and other healthcare providers involved in maternal-child health.

    Continuing Education (CE) credits are available for ACNM members and non-members who view this session via the ACNM Online Learning Center.


    Ep. 95 – Pregnancy, Rheumatoid Arthritis & Resilience

    If you have listened to the news lately, you have probably heard of the outbreak of lung injuries and related deaths associated with e-cigarettes and vaping products. Breaking news by health experts have reported that tetrahydrocannabinol (THC) was present in most of the samples of the products and lung tissue collected from the injured individuals, but Vitamin E acetate was present in all of the samples that have been tested to date. While this is a major breakthrough, the experts are not ready to draw any conclusion as of yet, for it is possible that there are other ingredients involved. Here at MotherToBaby we strive to prepare for the questions that may arise from hot topics such as this for the women and providers we serve. Therefore, this seems as good a time as any to ask, “What do we know about vaping and pregnancy?” For the purpose of this blog, I’m going to focus on nicotine vaping.

    What are ENDS?

    Electronic nicotine delivery systems (ENDS) describe a variety of products that includes vaporizers, vape pens, hookah pens, tank systems, mods and electronic cigarettes (e-cigarettes). Although ENDS were originally developed as an alternative way to inhale tobacco products (like nicotine), the devices are now also used to vape other substances, like cannabis. Each of these devices work by heating a liquid to produce an aerosol that a person inhales into their lungs producing a mist (vape). The liquid in ENDS can contain: nicotine, tetrahydrocannabinol (THC), cannabidiol (CBD) oils, propylene glycol and glycerol.

    Are ENDS a safer alternative than cigarette smoking in pregnancy?

    ENDS products came on the market in the U.S. in 2007, and their popularity quickly grew. One of the reasons they grew in popularity was due to the belief that they were a safer alternative to cigarettes, and could help smokers quit or reduce the amount of cigarettes they smoke. Cigarettes contain nicotine and many other agents as well as carbon monoxide. Cigarette smoking during pregnancy has been associated with an increased chance of miscarriage, cleft lip or palate, premature birth (before 37 weeks) and SIDS (sudden infant death syndrome). Smoking has also been associated with an increase chance of infertility, ectopic pregnancy (a pregnancy that occurs outside of the uterus) and complications with the placenta (i.e., placental abruption and placenta previa). The issues with cigarette smoking are not only limited to pregnancy but continue after the birth of the child as well. Smoking has been associated with a higher chance for asthma, childhood obesity and behavioral problems.

    While pregnancy is a big motivation for women to quit smoking, many struggle and look for a solution during pregnancy. Complicating the issue is the fact that many nicotine replacement therapies have not been well studied, and their effectiveness in helping smokers to quit has been questioned. Therefore, there is a hesitancy to use them. Also, medications to help stop smoking, like bupropion (Wellbutrin) and varenicline (Chantix), while not considered to pose a significant chance of birth defects, have limited data regarding their use in pregnancy. Recently the Food and Drug Administration (FDA) added warnings to the label regarding an increased chance of psychiatric effects including suicidal thoughts. This does not mean these medications should not be used by pregnant women who medically need them, but it shows how complex the issue of choosing an appropriate medication can be when you need to weigh the risks versus benefits. This leads pregnant women to find an alternative that might solve their problem and for some, ENDS seemed like the solution when they came on the market.

    The effects of inhaling the substances contained in ENDS are not known, especially when it comes to pregnancy. One study has shown that users of e-cigarettes can obtain a substantial amount of nicotine from e-cigarettes that is comparable to regular cigarettes, and we do know that nicotine can cross the placenta. Animal data shows that exposure to the chemicals found in e-cigarettes can cause various effects on offspring that include impact to the immune system, lung and heart function, and neuro-development (related to the function of brains and nerves); unfortunately, so far there is no data to suggest what the impact in human pregnancy might be. In addition, while ENDS products may reduce exposure to many of the toxins in cigarettes, there is still exposure to nicotine and other toxic chemicals, which can pose an increased chance of harm to pregnancies. Also, some ENDS products that have stated they were free of nicotine have been tested and were actually found to contain nicotine.

    There is no evidence to support ENDS as an effective way to stop smoking.

    A recent review of the use of ENDS products among non-pregnant patients found no strong evidence that they help in the effort to quit smoking. Regardless of the lung injuries that are currently in the news, health experts recommend that pregnant women avoid all ENDS use. Instead, any pregnant woman who is struggling to quit smoking should talk with their health care provider to discuss a plan that is suitable to them and contact resources such as the National Quitline Network (1-800-QUIT NOW). Quitting is best for you and your child so go ahead and clear the air. Trust me; your baby will thank you.

    References:

    Whittington J. et al. 2018. The Use of Electronic Cigarettes in Pregnancy: A Review of the Literature. Obstetrical and Gynecological Survey. 73(9): 544-549

    Committee on Underserved Women et al. 2017. Smoking Cessation During Pregnancy. 130(4): e200-e204.

    Kuehn B. 2019. Vaping and Pregnancy. JAMA. 321(14)

    Steenhuysen J. “UPDATE 1-U.S. CDC reports ‘breakthrough’ in vaping lung injury probe as cases top 2,000.” Reuters: Yahoo finance. 8 November 2019. Web 11 November 2019.